Healthcare Press Micronesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Micronesia.

Press releases published on September 1, 2026

10 hours ago

Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

Indeterminate GlobeNewswire

10 hours ago

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

10 hours ago

BridgeBio to Participate in September Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Vera Therapeutics to Participate at Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Ardelyx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings

Indeterminate GlobeNewswire

10 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

10 hours ago

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire

10 hours ago

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Indeterminate GlobeNewswire

11 hours ago

Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer

Indeterminate GlobeNewswire

11 hours ago

Kura Oncology to Participate in Three Investor Conferences in September

Indeterminate GlobeNewswire

11 hours ago

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire

11 hours ago

Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY

Indeterminate GlobeNewswire

11 hours ago

Immunocore to present at upcoming investor conferences

Indeterminate GlobeNewswire

11 hours ago

Sensory Education Launches Sensory Diversity: A New Neuro-Affirming Guide to Navigating Sensory Struggles

Indeterminate GlobeNewswire

11 hours ago

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

11 hours ago

Syndax Announces Participation in September Investor Conferences

Indeterminate GlobeNewswire

11 hours ago

Remix Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

11 hours ago

AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer

Indeterminate GlobeNewswire